title: [Epidemiological characteristics and mortality risk factors in patients admitted in hospitals with soft tissue infections. A multicentric STIMG (Soft Tissue Infections Malacitan Group) study results].
abstract: OBJECTIVE
  To describe the characteristics of patients admitted in hospitals with soft tissue infections, and analyse the variables whose died, in order to define risk groups.
  
  
  METHODS
  retrospective analysis of medical reports of all patient admitted during 2002 year for soft tissue infections in public malacitans hospitals. We excluded the patient with soft tissue infections associated with burns, surgery, pressure ulcers, and orbit cellulitis. We analysed clinical, biochemical variables and indications for yields and imaging tests, so the empiric antibiotic treatment established and its correlations with practice guidelines.
  
  
  RESULTS
  We analysed 391 admissions of 374 patients. Cellulitis was the most frequent diagnosis (69.3%). We did imaging tests in 51.6%. In 94.3% of cases were treated with empirics antibiotics. The most prescribed drug was amoxiciline plus clavulanate (39%). 27 patients died, 40.7% of them for septic cause. All deceased patients had chronic diseases. The only biochemical parameters associated with mortality were serum proteins and albumina (55 +/- 9 g/L vs. 63 +/- 8 g/L; p = 0.0231) and (22 +/- 7 g/L vs. 29 +/- 7 g/L; p = 0.0125) respectively.
  
  
  CONCLUSIONS
  Cellullitis are the most frequent soft tissue infections that requires admissions in hospitals. We overuse imaging test and don t follow the practice guidelines recommendations in antibiotic therapy. Primary soft issue infection s mortality is low and it s restricted to people with chronic illness, deep infections and bad nutritional status.
authors.affiliation: Servicios de Medicina Interna, Hospital de la Serranía (Ronda). f.salgado@terra.es
authors.forename: F
authors.initials: F
authors.lastname: Salgado Ordóñez
authors.forename: J
authors.initials: J
authors.lastname: Villar Jiménez
authors.forename: A
authors.initials: A
authors.lastname: Hidalgo Conde
authors.forename: A
authors.initials: A
authors.lastname: Villalobos Sánchez
authors.forename: J
authors.initials: J
authors.lastname: de la Torre Lima
authors.forename: J
authors.initials: J
authors.lastname: Aguilar García
authors.forename: I
authors.initials: I
authors.lastname: da Rocha Costa
authors.forename: M A
authors.initials: MA
authors.lastname: García Ordóñez
authors.forename: E
authors.initials: E
authors.lastname: Nuño Alvarez
authors.forename: C
authors.initials: C
authors.lastname: Ramos Cantes
authors.forename: M
authors.initials: M
authors.lastname: Martín Pérez
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D005260:Female; D006779:Hospitals, Public / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D012189:Retrospective Studies; D012307:Risk Factors; D018461:Soft Tissue Infections / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality*; D013030:Spain / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents